BRIGHTSIDE HEALTH

Mimi Winsberg, a board-certified psychiatrist, spent several years as a staff psychiatrist at Facebook helping employees with mental health. She saw up close what happened when high-stress environments collided with inadequate mental health support — even at a company with the resources to hire her.

When she left Facebook, she teamed up with Brad Kittredge to build the mental health platform she wished had existed for her patients.

They founded Brightside in 2019 with a specific clinical focus: depression and anxiety, the two most common and most undertreated mental health conditions in the United States. The platform was designed around the full clinical stack — not just therapy or just medication, but both together, managed by licensed providers through a digital-first interface.

Winsberg's clinical credibility was the unfair advantage. She knew what good mental health care looked like from the inside and could design a platform that clinicians would actually trust.

Brightside operates on a subscription model with tiered plans. Patients pay monthly for access to therapy, medication management, or both combined.

The pricing was designed to undercut the cost of traditional outpatient care while remaining above free or freemium mental health apps — positioned as real clinical care at a fraction of the access friction. Brightside accepts insurance for both therapy and psychiatry services, which is an important differentiator from many digital mental health platforms that operate cash-pay only.

Insurance coverage dramatically expands the addressable patient population. Brightside also tracks patient symptoms monthly using validated clinical tools and publishes outcome data showing what percentage of patients experience significant improvement — giving it the clinical credibility that payers and employers want to see.

The Brightside app is the patient-facing platform — a mobile and web interface where patients complete assessments, message their care team, and access therapy sessions. The medication management track pairs patients with a Brightside psychiatrist who evaluates, prescribes, and monitors treatment.

The therapy track pairs patients with a licensed therapist for structured CBT-based sessions. The combined plan gives patients access to both tracks with coordinated care between their therapist and prescriber.

Brightside's proprietary Precision Treatment approach uses patient response data to optimize medication selection — moving away from the trial-and-error approach that frustrates patients and clinicians in traditional psychiatry.

Brightside grew through a combination of direct-to-consumer digital marketing and B2B employer benefit partnerships. On the consumer side, the clinical credibility and insurance acceptance allowed it to reach patients who needed real treatment, not lifestyle support.

On the B2B side, Brightside pitched itself as a higher-acuity mental health partner to employers who already had basic coaching apps but needed somewhere to send employees with genuine depression diagnoses. Publishing outcome data publicly was a deliberate strategy to build trust with skeptical HR buyers and insurance partners who had been burned by mental health apps with no clinical evidence base.

Scaling licensed psychiatric care is fundamentally hard. Psychiatrists are in short supply nationally — the wait time to see one averages several months in most US markets.

Brightside built its own provider network, hiring and onboarding psychiatrists who wanted to practice via telemedicine. Managing clinical quality across a growing distributed provider network while maintaining the evidence-based standards that differentiate Brightside from lower-acuity competitors is the central operational challenge.

GV (Google Ventures) led Brightside's Series A in 2021, a significant signal given GV's portfolio depth in health tech. USVP (US Venture Partners) co-led the Series A and led the Series B in 2022.

Additional investors include SignalFire and Correlation Ventures. The GV involvement brought not just capital but access to technical resources and the credibility of one of the most recognized venture brands in Silicon Valley.